Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hanbing Yu
Institution:
First Hospital of China Medical University
Observed institutions:
First Hospital of China Medical University,
First Affiliated Hospital of Bengbu Medical College,
Liaoning Cancer Hospital & Institute
ORCID:
0000-0001-6117-9460
Observed ORCID:
0000-0001-6117-9460
OpenAlex ID:
A5074934131
Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells
2021
·
Rui Wang
, Hui Guo
, et al.
·
Inflammation
·
40
HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells
2022
·
Hui Guo
, Cheng Zhang
, et al.
·
Inflammation
·
21
AI-driven multi-omics integration of cancer-associated fibroblasts for prognostic modeling and therapeutic target discovery in head and neck squamous cell carcinoma
2025
·
Ning Zhao
, Jingru Zhang
, et al.
·
npj Precision Oncology
·
6
PDF
Prognosis Value of microRNA-3677-3p in Lung Adenocarcinoma and Its Regulatory Effect on Tumor Progression
2021
·
Jian Zhao
, Hanbing Yu
, et al.
·
Cancer Management and Research
·
5
PDF
CAPRIN1/TYMS/MTHFD2 axis promotes EMT process in nasopharyngeal carcinoma development
2025
·
Kunrong Wang
, Hanbing Yu
, et al.
·
The International Journal of Biochemistry & Cell Biology
·
2
RNA-binding protein tristetraprolin inhibits Th2 cell activation and differentiation in allergic rhinitis by promoting TRIM18 mRNA decay
2026
·
Dongsheng Xing
, Hongwei Cao
, et al.
·
Journal of Biological Chemistry
·
1
Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2025
·
Hongwei Cao
, Dongsheng Xing
, et al.
·
Molecular Cancer Research
·
1
Supplementary Figure S1 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Supplementary Table S2 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Data from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Supplementary Table S1 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Supplementary Figure S2 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Supplementary Figure S4 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Supplementary Figure S5 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Supplementary Figure S3 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC
2026
·
Hongwei Cao
, Dongsheng Xing
, et al.
Show more works
View as search
Works count:
15
Citation count:
76
H-index:
4
I10-index:
2
Year
Topic
Type